Nearly one-quarter of adults with metabolic dysfunction-associated steatotic liver disease and cirrhosis presented before age ...
Stocktwits on MSN
Altimmune receives FDA’s breakthrough therapy designation for its liver disease drug
Altimmune, Inc. (ALT) announced on Monday that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation ...
“Breaking Amish” star Jeremiah Raber was airlifted to a hospital with a very high, life-threatening blood sugar level and ...
Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the ...
Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback